🇪🇸 Spain · EU Public Tender
Principio activo es osimertinib
🏛️ Junta de Castilla y León — Gerencia Regional de Salud — Complejo Asistencial Universitario de Salamanca · 📍 Salamanca
494 K€
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | AstraZeneca Farmaceútica Spain, S. A |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.